what is this mean? Just the charts side by side aran't telling much.
Speaking of the sciences in both companies, I would say each of the drug candidate that IMU has, is at least as good as Efti, if not better.
And IMU got 5 viable candidates currently, wheras IMU only got one viable as I can see.
That one trick ponny status has to be a big part of why IMM got in this trouble.
Having say that, even just one single product, this one is valid and can be materialised anytime from now. Just where the heck is the money?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.010(4.17%) |
Mkt cap ! $365.0M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 24.0¢ | $1.350M | 5.550M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17018 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 547018 | 11 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |